Added value of F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study.
Fiche publication
Date publication
mars 2018
Journal
Alzheimer's & dementia : the journal of the Alzheimer's Association
Auteurs
Membres identifiés du Cancéropôle Est :
Pr VERGER Antoine
Tous les auteurs :
Ceccaldi M, Jonveaux T, Verger A, Krolak-Salmon P, Houzard C, Godefroy O, Shields T, Perrotin A, Gismondi R, Bullich S, Jovalekic A, Raffa N, Pasquier F, Semah F, Dubois B, Habert MO, Wallon D, Chastan M, Payoux P, , Stephens A, Guedj E
Lien Pubmed
Résumé
Although some studies have previously addressed the clinical impact of amyloid positron emission tomography (PET), none has specifically addressed its selective and hierarchical implementation in relation to cerebrospinal fluid analysis in a naturalistic setting.
Mots clés
Alzheimer's disease, Amyloid imaging, Clinical practice, Diagnosis, Florbetaben, Patient management
Référence
Alzheimers Dement. 2018 Mar;14(3):293-305